Along with decriminalizing cannabis moving forward, CAOA would mandate the expungement of existing low-level federal cannabis convictions and address restorative justice measures for the communities most impacted by the failed “war on drugs”.
The Secure and Fair Enforcement (“SAFE”) Banking Act has yet again failed to pass the United States Senate.
The Case Brooke Adams is a five-year-old girl diagnosed with Dravet Syndrome, a rare and severe form of epilepsy. Brooke currently uses medicinal cannabis-derived CBD oil to significantly reduce the frequency of seizures and medicinal cannabis-derived THC oil as an emergency medication to quickly stop seizures once they start. Brooke obtains both oils pursuant to a valid recommendation from a
Co-Author: Josh Zetlin This week the U.S. Food and Drug Administration (FDA) approved Epidiolex as a treatment for seizures associated with two rare and severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. Epidiolex, developed by GW Pharmaceuticals plc (Nasdaq: GWPH), a UK-based pharmaceutical company with U.S. operations, is the first FDA-approved drug made from a purified substance derived from
While cannabis remains a Schedule I controlled substance under federal law, 4 recent events at the national level point to growing support to allow states to determine their own legal cannabis regimes without federal interference. 1) Congress Extends the Rohrbacher-Blumenauer Amendment in the Federal Omnibus Spending Bill In late March, Congress passed and President Trump signed a $1.3 trillion omnibus
AG Jeff Sessions created a Task Force on Crime Reduction. One of its subcommittees has a charge related to cannabis: “Task Force subcommittees will also undertake a review of existing policies in the areas of charging, sentencing, and marijuana to ensure consistency with the Department’s overall strategy on reducing violent crime and with Administration goals and priorities.” Task Force members
Recreational cannabis legalization in California takes effect as early as January 1, 2018. Meanwhile, state and local governments are working to create a regulatory framework for this new market. What lessons might California learn from other states that have made a similar transition? OREGON’S EXPERIENCE: THE “EARLY START” PROGRAM One example is Oregon. Under its “Early Start” program, Oregon allowed existing
To date, two key factors guiding federal cannabis enforcement have been the Department of Justice’s “Cole Memo” (Cole memo) and the Rohrabacher-Farr amendment. While the appointment of Jeff Sessions to head the Department was not an encouraging sign, there is still federal interest in cannabis reform, especially among the group of lawmakers again proposing the “Respect State Marijuana Laws Act.” COLE MEMO The Cole